GlassScriptPhysician profile
Frank A Fedele
NPI 1972587996
$35,966.00
in general payments reported to CMS, 2019-2025
32 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,121 · 2020: $1,854 · 2021: $390 · 2022: $317 · 2023: $11K · 2024: $10K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $30K · Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $30,443.33 |
| Food and Beverage | $840.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $33,740.38 | 2019-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $396.91 | 2019-2025 | Lifevest |
| Amgen INC. | $170.03 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $160.71 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.03 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $135.72 | 2019-2022 | |
| Abiomed | $124.62 | 2022-2023 | Impella |
| Edwards Lifesciences Corporation | $119.56 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Actelion Pharmaceuticals US, INC. | $91.04 | 2019 | |
| Boston Scientific Corporation | $88.33 | 2021-2024 | Avvigo Guidance System |
| Astrazeneca Pharmaceuticals LP | $87.09 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $66.02 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $54.79 | 2021-2024 | Verquvo |
| Baxter Healthcare | $54.61 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Cardiovascular Systems INC. | $52.44 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $46.83 | 2025 | Puraply Wound Matrix |
| Kestra Medical Technology Services, INC. | $44.85 | 2024 | Assure Wcd |
| Elutia, INC. | $43.91 | 2021-2022 | |
| Medtronic, INC. | $43.69 | 2023-2024 | Telescope, Onyx Frontier |
| Amarin Pharma, INC. | $40.02 | 2020-2021 | |
| Teleflex LLC | $32.99 | 2022-2024 | Vascband |
| Pfizer INC. | $30.76 | 2019-2022 | |
| Vital Connect, INC | $28.35 | 2025 | Vitalpatch Rtm |
| Abbott Laboratories | $23.66 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $22.48 | 2024 | Arcalyst |
| Terumo Medical Corporation | $21.21 | 2025 | Glidewire, Metacross Otw, Angio-Seal |
| Arbor Pharmaceuticals, INC. | $19.07 | 2019 | |
| Smith+Nephew, INC. | $18.87 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $17.02 | 2021 | |
| Cardiva Medical, INC. | $15.20 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.12 | 2024 | Camzyos |
| Inspire Medical Systems, INC. | $12.69 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Fedele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.